An Association Between Selective Serotonin Reuptake Inhibitor Use and Serious Upper Gastrointestinal Bleeding

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 12, 2009, Pages 1314-1321

  Dall, Michael ^a,b   Schaffalitzky de Muckadell, Ove B ^b   Lassen, Annmarie Touborg ^b   Hansen, Jane Møller ^b   Hallas, Jesper ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DENMARK; DRUG EXPOSURE; FEMALE; GENDER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE AGGREGATION INHIBITION; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DENMARK; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 70849119641     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.08.019     Document Type: Article

References (42)

1. Percudani M., Barbui C., Fortino I., et al. Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord 83 (2004) 169-175
2. Meijer W.E., Heerdink E.R., Nolen W.A., et al. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164 (2004) 2367-2370
3. Li N., Wallen N.H., Ladjevardi M., et al. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 8 (1997) 517-523
4. Skop B.P., and Brown T.M. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 37 (1996) 12-16
5. Javors M.A., Houston J.P., Tekell J.L., et al. Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuropsychopharmacol 3 (2000) 229-235
6. de Abajo F.J., Garcia Rodriguez L.A., and Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: a population-based case-control study. Br Med J 319 (1999) 1106-1109
7. Dunn N.R., Pearce G.L., and Shakir S.A. Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding. BMJ 320 (2000) 1405-1406
8. van Walraven C., Mamdani M.M., Wells P.S., et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323 (2001) 655-658
9. Dalton S.O., Johansen C., Mellemkjaer L., et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163 (2003) 59-64
10. Tata L.J., Fortun P.J., Hubbard R.B., et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?. Aliment Pharmacol Ther 22 (2005) 175-181
11. Wessinger S., Kaplan M., Choi L., et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 23 (2006) 937-944
12. Helin-Salmivaara A., Huttunen T., Grönroos J.M., et al. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 63 (2007) 403-408
13. Opatrny L., Delaney J.A., and Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 66 (2008) 76-81
14. Lewis J.D., Strom B.L., Localio A.R., et al. Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf 17 (2008) 328-335
15. Vidal X., Ibáñez L., Vendrell L., et al. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants : a case-control study. Drug Saf 31 (2008) 159-168
16. de Abajo F.J., and García-Rodríguez L.A. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 65 (2008) 795-803
17. Targownik L.E., Bolton J.M., Metge C.J., et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 104 (2009) 1475-1482
18. Bak S., Tsiropoulos I., Kjærsgaard J.O., et al. Selective serotonin reuptake inhibitors and the risk of stroke: A population based case-control study. Stroke 33 (2002) 1465-1473
19. Maclure M., and Mittelman M.A. Should we use a case-crossover design?. Annu Rev Public Health 21 (2000) 193-221
20. Gaist D., Sørensen H.T., and Hallas J. The Danish Prescription Registries. Dan Med Bull 44 (1997) 445-448
21. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs and guidelines for ATC classification and DDD assignment (2006), Norwegian Institute of Public Health, Oslo
22. Frank L. Epidemiology. When an entire country is a cohort. Science 287 (2000) 2398-2399
23. Hallas J., Dall M., Andries A., et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 333 (2006) 726
24. Rothman K. Epidemiology: an introduction (2002), Oxford University Press, Oxford 87
25. Rosholm J.-U., Andersen M., and Gram L.F. Are there differences in the use of seelctive serotonin reuptake inhibitors and tricyclic antidepressants?. A prescription database study. Eur J Clin Pharmacol 56 (2001) 923-929
26. Lassen A., Hallas J., and Schaffalitzky de Muckadell O.B. Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study. BMJ 327 (2003) 603
27. Bjerre L.M., and LeLorier J. Expressing the magnitude of adverse effects in case-control studies. BMJ 320 (2000) 503-506
28. Weil J., Langman M.J., Wainwright P., et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 46 (2000) 27-31
29. Stack W.A., Atherton J.C., Hawkey G.M., et al. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther 16 (2002) 497-506
30. Andersen I.B., Jørgensen T., Bonnevie O., et al. Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology 11 (2000) 434-439
31. Kurata J.H., and Nogawa A.N. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 24 (1997) 2-17
32. Kaufman D.W., Kelly J.P., Wiholm B.E., et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol 94 (1999) 3189-3196
33. Mai K.S., Sandbaek A., Borch-Johnsen K., et al. Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes?. The ADDITION Study, Denmark. Diabet Med 24 (2007) 1121-1128
34. West R., McNeill A., and Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority Thorax 55 (2000) 987-999
35. Farrington C.P., Nash J., and Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol 143 (1996) 1165-1173
36. Danish Medical Agency. www.medstat.dk Accessed March 15, 2009
37. Atar D., Malinin A., Pokov A., et al. Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study. Neuropsychopharmacology 32 (2007) 2369-2374
38. Wägner A., Montero D., Mårtensson B., et al. Effects of fluoxetine treatment of platelet H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. Affect Disord 20 (1990) 101-113
39. Moride Y., and Abenhaim L. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol 47 (1994) 731-737
40. Movig K.L., Janssen M.W., de Waal Malefijt J., et al. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 163 (2003) 2354-2358
41. Lanas A., García-Rodríguez L.A., Arroyo M.T., et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55 (2006) 1731-1738
42. Lai K.C., Lam S.K., and Chu K.M. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346 (2002) 2033-2038